About
Dapagliflozin 10mg is an SGLT2 inhibitor prescribed for adults with type 2 diabetes, heart failure with reduced ejection fraction, and chronic kidney disease. It works by inhibiting the sodium-glucose co-transporter 2 in the renal tubules, which prevents the reabsorption of filtered glucose back into the bloodstream. This leads to increased urinary glucose excretion, thereby lowering blood glucose levels independently of insulin.
This mechanism also contributes to its profound beneficial effects on cardiovascular outcomes and kidney function. Clinical trials have shown that dapagliflozin significantly reduces the risk of cardiovascular death and hospitalization for heart failure, and slows the progression of chronic kidney disease, including reducing the risk of end-stage kidney disease. These broad protective effects make it a crucial therapeutic agent for improving long-term health and quality of life in these patient populations.
Uses
- Management of type 2 diabetes mellitus.
- To reduce the risk of cardiovascular death and hospitalization for heart failure.
- To reduce the risk of sustained eGFR decline, end-stage kidney disease, or renal death.
- As an adjunct to diet and exercise.
Directions For Use
Take orally once daily in the morning, with or without food.
Benefits
- Significant reduction in blood sugar.
- Supports weight management.
- Lowers blood pressure.
- Provides robust cardiovascular protection.
- Delays progression of kidney disease.
- Reduces risk of heart failure hospitalization.
Side Effects
- Genital mycotic infections.
- Urinary tract infections.
- Increased frequency of urination.
- Thirst.
- Dizziness.
- Hypotension.
- Diabetic ketoacidosis (rare).
- Acute kidney injury.
- Fournier's gangrene (extremely rare).
- Bone fractures.
- Hypoglycemia (when used with insulin or sulfonylureas).
- Volume depletion.
Safety Measures
- Alcohol - Limit alcohol intake to minimize the risk of dehydration and potential for ketoacidosis.
- Pregnancy - Not recommended during the second and third trimesters due to potential harm to the developing fetal kidney.
- Breastfeeding - Avoid use while breastfeeding as it is unknown if the drug is excreted in human milk and could affect the infant.
- Liver - Use with caution in patients with severe hepatic impairment; close monitoring for adverse effects is advised.
- Kidney - Contraindicated or requires dose adjustment in patients with severe renal impairment or end-stage renal disease.
- Lung - Generally considered safe for individuals with lung conditions; no specific pulmonary contraindications.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!